nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—TOP2A—polycystic ovary syndrome	0.807	1	CbGaD
Amsacrine—NCOA3—adrenal cortex—polycystic ovary syndrome	0.00495	0.0734	CbGeAlD
Amsacrine—NCOA3—endometrium—polycystic ovary syndrome	0.00442	0.0655	CbGeAlD
Amsacrine—NCOA3—uterus—polycystic ovary syndrome	0.00407	0.0604	CbGeAlD
Amsacrine—NCOA3—pituitary gland—polycystic ovary syndrome	0.004	0.0593	CbGeAlD
Amsacrine—NCOA3—adipose tissue—polycystic ovary syndrome	0.00398	0.0591	CbGeAlD
Amsacrine—CYP2D6—urine—polycystic ovary syndrome	0.00375	0.0555	CbGeAlD
Amsacrine—NCOA3—adrenal gland—polycystic ovary syndrome	0.00357	0.053	CbGeAlD
Amsacrine—NCOA3—female gonad—polycystic ovary syndrome	0.00333	0.0494	CbGeAlD
Amsacrine—NCOA3—vagina—polycystic ovary syndrome	0.00331	0.0491	CbGeAlD
Amsacrine—NCOA3—endocrine gland—polycystic ovary syndrome	0.0031	0.0459	CbGeAlD
Amsacrine—TOP2A—endometrium—polycystic ovary syndrome	0.00259	0.0384	CbGeAlD
Amsacrine—TOP2A—uterus—polycystic ovary syndrome	0.00239	0.0354	CbGeAlD
Amsacrine—TOP2A—adipose tissue—polycystic ovary syndrome	0.00234	0.0346	CbGeAlD
Amsacrine—TOP2A—adrenal gland—polycystic ovary syndrome	0.0021	0.0311	CbGeAlD
Amsacrine—TOP2A—female gonad—polycystic ovary syndrome	0.00195	0.029	CbGeAlD
Amsacrine—TOP2A—vagina—polycystic ovary syndrome	0.00194	0.0288	CbGeAlD
Amsacrine—KCNH2—endometrium—polycystic ovary syndrome	0.00145	0.0215	CbGeAlD
Amsacrine—KCNH2—uterus—polycystic ovary syndrome	0.00134	0.0198	CbGeAlD
Amsacrine—KCNH2—pituitary gland—polycystic ovary syndrome	0.00131	0.0195	CbGeAlD
Amsacrine—KCNH2—adrenal gland—polycystic ovary syndrome	0.00117	0.0174	CbGeAlD
Amsacrine—KCNH2—female gonad—polycystic ovary syndrome	0.0011	0.0162	CbGeAlD
Amsacrine—KCNH2—vagina—polycystic ovary syndrome	0.00109	0.0161	CbGeAlD
Amsacrine—KCNH2—endocrine gland—polycystic ovary syndrome	0.00102	0.0151	CbGeAlD
Amsacrine—ABCB1—embryo—polycystic ovary syndrome	0.000871	0.0129	CbGeAlD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—polycystic ovary syndrome	0.000765	0.00618	CbGpPWpGaD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—LEP—polycystic ovary syndrome	0.000737	0.00595	CbGpPWpGaD
Amsacrine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000714	0.0106	CbGeAlD
Amsacrine—NCOA3—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.000684	0.00553	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000682	0.00551	CbGpPWpGaD
Amsacrine—NCOA3—PPARA activates gene expression—NCOR1—polycystic ovary syndrome	0.000673	0.00544	CbGpPWpGaD
Amsacrine—CYP2D6—female gonad—polycystic ovary syndrome	0.000668	0.0099	CbGeAlD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—polycystic ovary syndrome	0.000659	0.00532	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—ATF1—polycystic ovary syndrome	0.000645	0.0052	CbGpPWpGaD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—PPARG—polycystic ovary syndrome	0.000642	0.00518	CbGpPWpGaD
Amsacrine—NCOA3—PPARA activates gene expression—CYP1A1—polycystic ovary syndrome	0.000638	0.00515	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000637	0.00515	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000637	0.00515	CbGpPWpGaD
Amsacrine—ABCB1—endometrium—polycystic ovary syndrome	0.000637	0.00945	CbGeAlD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000629	0.00508	CbGpPWpGaD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—polycystic ovary syndrome	0.000625	0.00504	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.000622	0.00503	CbGpPWpGaD
Amsacrine—CYP2D6—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000622	0.00502	CbGpPWpGaD
Amsacrine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000621	0.00921	CbGeAlD
Amsacrine—TOP2A—Circadian rythm related genes—CLDN4—polycystic ovary syndrome	0.000616	0.00497	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	0.000615	0.00496	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—AR—polycystic ovary syndrome	0.000598	0.00483	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CCNE2—polycystic ovary syndrome	0.000597	0.00482	CbGpPWpGaD
Amsacrine—ABCB1—uterus—polycystic ovary syndrome	0.000587	0.00871	CbGeAlD
Amsacrine—ABCB1—pituitary gland—polycystic ovary syndrome	0.000577	0.00855	CbGeAlD
Amsacrine—ABCB1—adipose tissue—polycystic ovary syndrome	0.000574	0.00852	CbGeAlD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NRG1—polycystic ovary syndrome	0.000572	0.00462	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDC6—polycystic ovary syndrome	0.000561	0.00453	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000534	0.00431	CbGpPWpGaD
Amsacrine—ABCB1—adrenal gland—polycystic ovary syndrome	0.000515	0.00764	CbGeAlD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000509	0.00411	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000506	0.00409	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—STAR—polycystic ovary syndrome	0.000487	0.00393	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000483	0.0039	CbGpPWpGaD
Amsacrine—NCOA3—PPARA activates gene expression—PPARG—polycystic ovary syndrome	0.000483	0.0039	CbGpPWpGaD
Amsacrine—ABCB1—female gonad—polycystic ovary syndrome	0.00048	0.00712	CbGeAlD
Amsacrine—ABCB1—vagina—polycystic ovary syndrome	0.000477	0.00708	CbGeAlD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—polycystic ovary syndrome	0.000472	0.00381	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.000472	0.00381	CbGpPWpGaD
Amsacrine—ABCB1—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000471	0.0038	CbGpPWpGaD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—polycystic ovary syndrome	0.000454	0.00367	CbGpPWpGaD
Amsacrine—ABCB1—endocrine gland—polycystic ovary syndrome	0.000447	0.00662	CbGeAlD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—RRM2—polycystic ovary syndrome	0.000438	0.00354	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000437	0.00352	CbGpPWpGaD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—polycystic ovary syndrome	0.00043	0.00348	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000411	0.00332	CbGpPWpGaD
Amsacrine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000406	0.00328	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000403	0.00325	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—NMNAT3—polycystic ovary syndrome	0.000393	0.00317	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	0.000384	0.0031	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.000381	0.00308	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000375	0.00302	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000366	0.00296	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SUOX—polycystic ovary syndrome	0.000359	0.0029	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—LPCAT2—polycystic ovary syndrome	0.000359	0.0029	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000355	0.00286	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—RAB2A—polycystic ovary syndrome	0.000341	0.00275	CbGpPWpGaD
Amsacrine—CYP2D6—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00034	0.00274	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.000338	0.00273	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ISYNA1—polycystic ovary syndrome	0.000334	0.0027	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CCNB1—polycystic ovary syndrome	0.000332	0.00268	CbGpPWpGaD
Amsacrine—CYP2D6—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000327	0.00264	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000326	0.00264	CbGpPWpGaD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—polycystic ovary syndrome	0.000325	0.00263	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	0.00031	0.0025	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB1—polycystic ovary syndrome	0.000308	0.00249	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000305	0.00246	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.000295	0.00238	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000289	0.00233	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—TEAD2—polycystic ovary syndrome	0.000284	0.00229	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKR1C2—polycystic ovary syndrome	0.000284	0.00229	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000277	0.00224	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000273	0.0022	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—polycystic ovary syndrome	0.000271	0.00219	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—DLG4—polycystic ovary syndrome	0.00027	0.00218	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000269	0.00217	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000268	0.00217	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000253	0.00205	CbGpPWpGaD
Amsacrine—CYP2D6—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.000252	0.00204	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.000249	0.00201	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000247	0.00199	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.000241	0.00195	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PNPLA2—polycystic ovary syndrome	0.000238	0.00192	CbGpPWpGaD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000238	0.00192	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—FOXP3—polycystic ovary syndrome	0.000237	0.00191	CbGpPWpGaD
Amsacrine—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000235	0.0019	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TH—polycystic ovary syndrome	0.000234	0.00189	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000232	0.00187	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SRD5A1—polycystic ovary syndrome	0.000226	0.00182	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000223	0.0018	CbGpPWpGaD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000221	0.00179	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.000219	0.00177	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000219	0.00177	CbGpPWpGaD
Amsacrine—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000218	0.00176	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000217	0.00175	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—TFRC—polycystic ovary syndrome	0.000215	0.00174	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—STAR—polycystic ovary syndrome	0.000215	0.00174	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000213	0.00172	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.000206	0.00166	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000204	0.00165	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000202	0.00163	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000199	0.00161	CbGpPWpGaD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—polycystic ovary syndrome	0.000197	0.00159	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000196	0.00158	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000193	0.00156	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—HMMR—polycystic ovary syndrome	0.000192	0.00155	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000185	0.00149	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDC6—polycystic ovary syndrome	0.000184	0.00149	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—HSD3B1—polycystic ovary syndrome	0.000183	0.00148	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000182	0.00147	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000181	0.00146	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—DLG4—polycystic ovary syndrome	0.000181	0.00146	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000179	0.00145	CbGpPWpGaD
Amsacrine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000178	0.00144	CbGpPWpGaD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000175	0.00141	CbGpPWpGaD
Amsacrine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000173	0.00139	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000171	0.00138	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—LHB—polycystic ovary syndrome	0.000167	0.00135	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—LEP—polycystic ovary syndrome	0.000167	0.00135	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—HSD3B2—polycystic ovary syndrome	0.000163	0.00132	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.000161	0.0013	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKR1C1—polycystic ovary syndrome	0.000158	0.00128	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000152	0.00122	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.00015	0.00121	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000145	0.00117	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—PPARG—polycystic ovary syndrome	0.000145	0.00117	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—RRM2—polycystic ovary syndrome	0.000144	0.00116	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—INS—polycystic ovary syndrome	0.000142	0.00115	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000142	0.00115	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000141	0.00114	CbGpPWpGaD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000141	0.00114	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—RRM2—polycystic ovary syndrome	0.000141	0.00114	CbGpPWpGaD
Amsacrine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000139	0.00112	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—AKT2—polycystic ovary syndrome	0.000138	0.00111	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000136	0.0011	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—YAP1—polycystic ovary syndrome	0.000136	0.0011	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000136	0.0011	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000133	0.00107	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000131	0.00105	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—NAMPT—polycystic ovary syndrome	0.00013	0.00105	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00013	0.00105	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000129	0.00104	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000129	0.00104	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000128	0.00103	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—LMNA—polycystic ovary syndrome	0.000126	0.00102	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000124	0.001	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000122	0.000983	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000122	0.000982	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.00012	0.000972	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP17A1—polycystic ovary syndrome	0.00012	0.000966	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000118	0.00095	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000116	0.000934	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000114	0.000923	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000114	0.000921	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000113	0.00091	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000109	0.000879	CbGpPWpGaD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000105	0.000849	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—TH—polycystic ovary syndrome	0.000104	0.000836	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000102	0.000827	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000101	0.000816	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000101	0.000813	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	9.68e-05	0.000781	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	9.57e-05	0.000773	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	9.54e-05	0.00077	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	9.52e-05	0.000769	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP19A1—polycystic ovary syndrome	9.47e-05	0.000765	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	9.44e-05	0.000763	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	9.39e-05	0.000758	CbGpPWpGaD
Amsacrine—Lethargy—Metformin—polycystic ovary syndrome	9.24e-05	0.0558	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	9.2e-05	0.000743	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—VEGFA—polycystic ovary syndrome	8.99e-05	0.000726	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	8.75e-05	0.000707	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	8.52e-05	0.000688	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GNAS—polycystic ovary syndrome	8.45e-05	0.000683	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	8.43e-05	0.000681	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—NCOR1—polycystic ovary syndrome	8.05e-05	0.00065	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP1A1—polycystic ovary syndrome	7.63e-05	0.000616	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	7.53e-05	0.000608	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	7.43e-05	0.0006	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	7.15e-05	0.000578	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—MTHFR—polycystic ovary syndrome	7.12e-05	0.000575	CbGpPWpGaD
Amsacrine—Infestation NOS—Metformin—polycystic ovary syndrome	6.97e-05	0.0421	CcSEcCtD
Amsacrine—Infestation—Metformin—polycystic ovary syndrome	6.97e-05	0.0421	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	6.62e-05	0.000535	CbGpPWpGaD
Amsacrine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	6.6e-05	0.0399	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	6.5e-05	0.000525	CbGpPWpGaD
Amsacrine—Bradycardia—Metformin—polycystic ovary syndrome	6.37e-05	0.0385	CcSEcCtD
Amsacrine—Hepatitis—Metformin—polycystic ovary syndrome	6.26e-05	0.0378	CcSEcCtD
Amsacrine—Hypoaesthesia—Metformin—polycystic ovary syndrome	6.23e-05	0.0376	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—IL6—polycystic ovary syndrome	6.22e-05	0.000502	CbGpPWpGaD
Amsacrine—Connective tissue disorder—Metformin—polycystic ovary syndrome	6.15e-05	0.0372	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	6.09e-05	0.000492	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	6.07e-05	0.00049	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.99e-05	0.000484	CbGpPWpGaD
Amsacrine—Cardiac disorder—Metformin—polycystic ovary syndrome	5.81e-05	0.0351	CcSEcCtD
Amsacrine—NCOA3—Metabolism—PPARG—polycystic ovary syndrome	5.77e-05	0.000466	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—POMC—polycystic ovary syndrome	5.69e-05	0.00046	CbGpPWpGaD
Amsacrine—Angiopathy—Metformin—polycystic ovary syndrome	5.68e-05	0.0343	CcSEcCtD
Amsacrine—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	5.67e-05	0.000458	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—INS—polycystic ovary syndrome	5.66e-05	0.000457	CbGpPWpGaD
Amsacrine—Mediastinal disorder—Metformin—polycystic ovary syndrome	5.64e-05	0.0341	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	5.63e-05	0.000454	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—IL6—polycystic ovary syndrome	5.6e-05	0.000452	CbGpPWpGaD
Amsacrine—Malnutrition—Metformin—polycystic ovary syndrome	5.45e-05	0.0329	CcSEcCtD
Amsacrine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	5.34e-05	0.000431	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	5.18e-05	0.000419	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	5.18e-05	0.000419	CbGpPWpGaD
Amsacrine—Vision blurred—Metformin—polycystic ovary syndrome	5.14e-05	0.031	CcSEcCtD
Amsacrine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	4.89e-05	0.000395	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	4.89e-05	0.000395	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	4.82e-05	0.000389	CbGpPWpGaD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	4.61e-05	0.0278	CcSEcCtD
Amsacrine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	4.54e-05	0.000367	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	4.53e-05	0.000366	CbGpPWpGaD
Amsacrine—Infection—Metformin—polycystic ovary syndrome	4.42e-05	0.0267	CcSEcCtD
Amsacrine—Thrombocytopenia—Metformin—polycystic ovary syndrome	4.36e-05	0.0263	CcSEcCtD
Amsacrine—Skin disorder—Metformin—polycystic ovary syndrome	4.32e-05	0.0261	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	4.25e-05	0.000343	CbGpPWpGaD
Amsacrine—Anorexia—Metformin—polycystic ovary syndrome	4.24e-05	0.0256	CcSEcCtD
Amsacrine—Hypotension—Metformin—polycystic ovary syndrome	4.16e-05	0.0251	CcSEcCtD
Amsacrine—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	4.1e-05	0.000331	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	4.1e-05	0.000331	CbGpPWpGaD
Amsacrine—Paraesthesia—Metformin—polycystic ovary syndrome	3.99e-05	0.0241	CcSEcCtD
Amsacrine—Dyspnoea—Metformin—polycystic ovary syndrome	3.97e-05	0.024	CcSEcCtD
Amsacrine—Decreased appetite—Metformin—polycystic ovary syndrome	3.87e-05	0.0234	CcSEcCtD
Amsacrine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	3.86e-05	0.000312	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	3.86e-05	0.000312	CbGpPWpGaD
Amsacrine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	3.84e-05	0.0232	CcSEcCtD
Amsacrine—Fatigue—Metformin—polycystic ovary syndrome	3.84e-05	0.0232	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.71e-05	0.0003	CbGpPWpGaD
Amsacrine—Feeling abnormal—Metformin—polycystic ovary syndrome	3.67e-05	0.0221	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.65e-05	0.000295	CbGpPWpGaD
Amsacrine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	3.64e-05	0.022	CcSEcCtD
Amsacrine—Urticaria—Metformin—polycystic ovary syndrome	3.53e-05	0.0214	CcSEcCtD
Amsacrine—Abdominal pain—Metformin—polycystic ovary syndrome	3.52e-05	0.0212	CcSEcCtD
Amsacrine—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	3.43e-05	0.000277	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.39e-05	0.000274	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	3.26e-05	0.000263	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	3.24e-05	0.000261	CbGpPWpGaD
Amsacrine—Asthenia—Metformin—polycystic ovary syndrome	3.19e-05	0.0193	CcSEcCtD
Amsacrine—ABCB1—Metabolism—STAR—polycystic ovary syndrome	3.11e-05	0.000251	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.1e-05	0.000251	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	3.07e-05	0.000248	CbGpPWpGaD
Amsacrine—Diarrhoea—Metformin—polycystic ovary syndrome	3.04e-05	0.0184	CcSEcCtD
Amsacrine—Dizziness—Metformin—polycystic ovary syndrome	2.94e-05	0.0178	CcSEcCtD
Amsacrine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2.93e-05	0.000236	CbGpPWpGaD
Amsacrine—Vomiting—Metformin—polycystic ovary syndrome	2.83e-05	0.0171	CcSEcCtD
Amsacrine—Rash—Metformin—polycystic ovary syndrome	2.8e-05	0.0169	CcSEcCtD
Amsacrine—Dermatitis—Metformin—polycystic ovary syndrome	2.8e-05	0.0169	CcSEcCtD
Amsacrine—Headache—Metformin—polycystic ovary syndrome	2.79e-05	0.0168	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.78e-05	0.000224	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	2.77e-05	0.000224	CbGpPWpGaD
Amsacrine—Nausea—Metformin—polycystic ovary syndrome	2.64e-05	0.016	CcSEcCtD
Amsacrine—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	2.64e-05	0.000213	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	2.61e-05	0.000211	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.61e-05	0.00021	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.49e-05	0.000201	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.41e-05	0.000194	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.35e-05	0.00019	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.28e-05	0.000184	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	2.27e-05	0.000183	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	2.22e-05	0.000179	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	2.15e-05	0.000173	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	2.1e-05	0.000169	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	2.03e-05	0.000164	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.98e-05	0.00016	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.96e-05	0.000158	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.91e-05	0.000155	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.88e-05	0.000152	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.86e-05	0.00015	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.85e-05	0.000149	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.77e-05	0.000143	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.75e-05	0.000142	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.75e-05	0.000141	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.73e-05	0.00014	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.65e-05	0.000134	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.63e-05	0.000131	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.49e-05	0.000121	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.45e-05	0.000117	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.41e-05	0.000114	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.37e-05	0.000111	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.37e-05	0.00011	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.29e-05	0.000104	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.22e-05	9.85e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.16e-05	9.39e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.15e-05	9.29e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.1e-05	8.9e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.1e-05	8.85e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.04e-05	8.39e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.03e-05	8.3e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	9.68e-06	7.82e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	8.33e-06	6.73e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	8.22e-06	6.64e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—INS—polycystic ovary syndrome	8.17e-06	6.6e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	7.85e-06	6.34e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	7.74e-06	6.25e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	7.7e-06	6.22e-05	CbGpPWpGaD
